Telogen effluvium causes temporary hair loss, especially in women.
1 citations
,
January 2012 in “Jounal of The Korean Society of cosmetology” Tremella fuciformis Berk helps protect hair from stress-related damage.
July 2024 in “Journal of Investigative Dermatology” Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.
March 2025 in “Journal of Cosmetic Dermatology” Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.
23 citations
,
January 2012 in “International Food Research Journal” Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.
January 2023 in “Psychology” Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.
March 2015 in “CRC Press eBooks” Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.
5 citations
,
September 2020 in “Proceedings - Baylor University. Medical Center” Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.
2 citations
,
January 2012 in “Hair therapy & transplantation” Low serum ferritin levels are not closely linked to telogen effluvium in women.
July 2025 in “International Journal of Trichology” Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.
1 citations
,
May 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” The fer-ts mutation in plants prevents root hair growth at high temperatures.
11 citations
,
January 2018 in “Acta dermato-venereologica” Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.
August 2024 in “International Journal of Health Science” Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.
Low levels of tenuazonic acid can severely damage vital organs.
June 2019 in “Journal of Medical Sciences” Low serum ferritin levels are linked to hair loss in women.
January 2000 in “Time to knit” SFE is a better extraction method, and the HPTLC method is effective for analyzing wedelolactone in E. alba.
May 2025 in “JEADV Clinical Practice” Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.
December 2024 in “Medical alphabet” Understanding and addressing the causes of telogen effluvium is crucial for effective treatment.
13 citations
,
May 1993 in “International Journal of Dermatology” The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.
August 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.
September 2021 in “CRC Press eBooks” Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.
July 2021 in “Zenodo (CERN European Organization for Nuclear Research)” Mealworm farming is a sustainable, low-cost way to produce high-quality protein-rich feed.
1 citations
,
June 2025 in “Frontiers in Genetics” Key genes IRF2BP2 and EGFR are linked to Hetian sheep's double-coat fleece.
3 citations
,
April 2012 in “Current Research in Pharmaceutical Sciences” Fenugreek has many health benefits, including antimicrobial and anti-inflammatory effects.
1 citations
,
January 2023 in “International Journal of Molecular Sciences” Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.
3 citations
,
February 2008 in “Basic and clinical dermatology” Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
2 citations
,
January 2024 in “Journal of Pharmacognosy and Phytochemistry” Teak has valuable compounds for medicine, cosmetics, and industry, with potential in cancer treatment and biodiesel production.
25 citations
,
April 2008 in “Clinical and experimental dermatology” EFFC might be common but underreported.
April 2012 in “Informa Healthcare eBooks” Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.
August 2018 in “Journal of the American Academy of Dermatology” Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.